Barkat Pharmaceutical Group

Barkat Pharmaceutical Group is a leading Iranian pharmaceutical conglomerate that controls a significant portion of the country's medicinal supply chain. As a subsidiary of the Execution of Imam Khomeini's Order (EIKO), the group manages over 20 subsidiaries specializing in research, development, manufacturing, and distribution. The company gained international prominence for developing COVIran Barekat, Iran's first domestically produced COVID-19 vaccine. Its operations are centered in the Barkat Pharmaceutical Industrial Town, one of the largest specialized pharmaceutical hubs in the Middle East, focusing on advanced therapies including biosimilars, cell therapy, and oncology treatments.